These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 2139274

  • 21. Pharmacokinetics of acitretin.
    Lambert WE, Meyer E, De Leenheer AP, De Bersaques J, Kint AH.
    Acta Derm Venereol Suppl (Stockh); 1994; 186():122-3. PubMed ID: 8073811
    [Abstract] [Full Text] [Related]

  • 22. [Acitretin therapy in keratinization disorders].
    van Dooren-Greebe RJ, van de Kerkhof PC, Steijlen PM, Happle R.
    Ned Tijdschr Geneeskd; 1990 Oct 13; 134(41):1995-2000. PubMed ID: 2146515
    [Abstract] [Full Text] [Related]

  • 23. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis.
    Vahlquist C, Selinus I, Vessby B.
    Acta Derm Venereol; 1988 Oct 13; 68(4):300-5. PubMed ID: 2459874
    [Abstract] [Full Text] [Related]

  • 24. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP, Matt LH, Lowe NJ.
    Arch Dermatol; 1987 Jan 13; 123(1):55-8. PubMed ID: 2948451
    [Abstract] [Full Text] [Related]

  • 25. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats.
    Chien DS, Sandri RB, Tang-Liu DS.
    Drug Metab Dispos; 1992 Jan 13; 20(2):211-7. PubMed ID: 1352212
    [Abstract] [Full Text] [Related]

  • 26. Acitretin is converted to etretinate only during concomitant alcohol intake.
    Grønhøj Larsen F, Steinkjer B, Jakobsen P, Hjorter A, Brockhoff PB, Nielsen-Kudsk F.
    Br J Dermatol; 2000 Dec 13; 143(6):1164-9. PubMed ID: 11122016
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic profile of two aromatic retinoids (etretinate and acitretin) in the obese Zucker rat.
    McNamara PJ, Blouin RA.
    J Pharm Sci; 1990 Apr 13; 79(4):301-4. PubMed ID: 2141075
    [Abstract] [Full Text] [Related]

  • 28. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G, Meyer-Hamme S, Ippen H.
    Arch Dermatol; 1982 Feb 13; 118(2):97-100. PubMed ID: 7059226
    [Abstract] [Full Text] [Related]

  • 29. Identification of etretinate metabolites in human bile.
    Vane FM, Buggé CJ, Rodriguez LC.
    Drug Metab Dispos; 1989 Feb 13; 17(3):275-9. PubMed ID: 2568908
    [Abstract] [Full Text] [Related]

  • 30. The pharmacokinetics of etretinate and its metabolites in the dog.
    Thongnopnua P, Massarella JW, Zimmerman CL.
    Drug Metab Dispos; 1989 Feb 13; 17(5):473-80. PubMed ID: 2573489
    [Abstract] [Full Text] [Related]

  • 31. Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose.
    Löfberg B, Chahoud I, Bochert G, Nau H.
    Teratology; 1990 Jun 13; 41(6):707-16. PubMed ID: 2141193
    [Abstract] [Full Text] [Related]

  • 32. High-performance liquid chromatographic determination of etretinate and all-trans- and 13-cis-acitretin in human plasma.
    De Leenheer AP, Lambert WE, De Bersaques JP, Kint AH.
    J Chromatogr; 1990 Feb 02; 500():637-42. PubMed ID: 2139439
    [Abstract] [Full Text] [Related]

  • 33. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G, Thiel R, Chahoud I, Nau H.
    Toxicol Appl Pharmacol; 1997 Apr 02; 143(2):436-44. PubMed ID: 9144460
    [Abstract] [Full Text] [Related]

  • 34. Oral acitretin in psoriasis: drug and vitamin A concentrations in plasma, skin and adipose tissue.
    Larsen FG, Vahlquist C, Andersson E, Törma H, Kragballe K, Vahlquist A.
    Acta Derm Venereol; 1992 Apr 02; 72(2):84-8. PubMed ID: 1350412
    [Abstract] [Full Text] [Related]

  • 35. [Distribution of acitretin in human skin].
    Surber C, Laugier JP, Geiger JM, Durand A, Rufli T, Maibach HI.
    Ann Dermatol Venereol; 1993 Apr 02; 120(1):116-22. PubMed ID: 8338323
    [Abstract] [Full Text] [Related]

  • 36. [Serum triglycerides and cholesterin in patients with skin diseases during oral treatment with aromatic retinoid (author's transl)].
    Gollnick H, Orfanos CE.
    Z Hautkr; 1981 Sep 15; 56(18):1183-96. PubMed ID: 7293303
    [Abstract] [Full Text] [Related]

  • 37. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. I. Acitretin.
    Eisenhardt EU, Bickel MH.
    Drug Metab Dispos; 1994 Sep 15; 22(1):26-30. PubMed ID: 8149885
    [Abstract] [Full Text] [Related]

  • 38. The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients.
    Larsen FG, Jakobsen P, Eriksen H, Grønhøj J, Kragballe K, Nielsen-Kudsk F.
    J Clin Pharmacol; 1991 May 15; 31(5):477-83. PubMed ID: 1828811
    [Abstract] [Full Text] [Related]

  • 39. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B, Reiners J, Spielmann H, Nau H.
    Dev Pharmacol Ther; 1990 May 15; 15(1):45-51. PubMed ID: 2147001
    [Abstract] [Full Text] [Related]

  • 40. Etretinate may work where acitretin fails.
    Bleiker TO, Bourke JF, Graham-Brown RA, Hutchinson PE.
    Br J Dermatol; 1997 Mar 15; 136(3):368-70. PubMed ID: 9115918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.